USING VERIFIED CLINICAL TRIALS' DATABASE REGISTRY TO DETERMINE THE PREVALENCE OF AND PREVENT EXCLUSION/INCLUSION RELATED PROTOCOL VIOLATIONS IN EARLY PHASE CLINICAL TRIALS.

Zhang Y.; Wang Y.; DiBartolo-Cordovano R.; Weingard K. K.; Efros M. D.

首页> 外文期刊>Clinical Pharmacology and Therapeutics >USING VERIFIED CLINICAL TRIALS' DATABASE REGISTRY TO DETERMINE THE PREVALENCE OF AND PREVENT EXCLUSION/INCLUSION RELATED PROTOCOL VIOLATIONS IN EARLY PHASE CLINICAL TRIALS.

【24h】

USING VERIFIED CLINICAL TRIALS' DATABASE REGISTRY TO DETERMINE THE PREVALENCE OF AND PREVENT EXCLUSION/INCLUSION RELATED PROTOCOL VIOLATIONS IN EARLY PHASE CLINICAL TRIALS.

机译：使用已经过认证的临床试验数据库登记，以确定早期临床试验中的普遍存在和防止排除/包含相关议定书的侵犯行为。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical Pharmacology and Therapeutics》 |2019年第1期|共1页
作者
Zhang Y.; Wang Y.; DiBartolo-Cordovano R.; Weingard K. K.; Efros M. D.;
展开▼
作者单位

Columbia Univ Med Ctr New York NY USA;

Columbia Univ Med Ctr New York NY USA;

Verified Clin Trials Garden City NY USA;

Verified Clin Trials Garden City NY USA;

Verified Clin Trials Garden City NY USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. USING VERIFIED CLINICAL TRIALS' DATABASE REGISTRY TO DETERMINE THE PREVALENCE OF AND PREVENT EXCLUSION/INCLUSION RELATED PROTOCOL VIOLATIONS IN EARLY PHASE CLINICAL TRIALS. [J] . Zhang Y., Wang Y., DiBartolo-Cordovano R., Clinical Pharmacology and Therapeutics . 2019,第Suppla1期

机译：使用已经过认证的临床试验数据库登记，以确定早期临床试验中的普遍存在和防止排除/包含相关议定书的侵犯行为。
2. A Cross-sectional Survey and Cross-sectional Clinical Trial to Determine the Prevalence and Management of Eye Movement Disorders and Vestibular Dysfunction in Post-Stroke Patients in the Sub-Acute Phase: Protocol [J] . Andoret van Wyk, Carina A. Eksteen, Piet J. Becker, Frontiers in Neurology . 2016,第1期

机译：横断面调查和横断面临床试验，用于确定亚急性期中风后患者的眼球运动障碍和前庭功能障碍的患病率和管理：方案
3. A multicentre phase III randomised controlled single-masked clinical trial evaluating the clinical efficacy and safety of light-masks at preventing dark-adaptation in the treatment of early diabetic macular oedema (CLEOPATRA): study protocol for a randomised controlled trial [J] . Sobha Sivaprasad, Geoffrey Arden, A T Prevost, Trials . 2014,第1期

机译：一项多中心III期随机对照单掩盖临床试验，评估了遮光膜在预防早期糖尿病性黄斑水肿（CLEOPATRA）中预防黑暗适应的临床疗效和安全性：一项随机对照试验的研究方案
4. Automatic Segregation and Classification of Inclusion and Exclusion Criteria of Clinical Trials to Improve Patient Eligibility Matching [C] . Tirthankar Dasgupta, Ishani Mondal, Abir Naskar, Health Intelligence Workshop;Association for the Advancement of Artificial Intelligence Annual Conference . 2020

机译：临床试验的自动分离与分类，改善患者资格匹配的临床试验
5. Examination of novel statistical designs for phase II and phase III clinical trials. [D] . Ayanlowo, Ayanbola Olajumoke. 2007

机译：检验II期和III期临床试验的新颖统计设计。
6. A Cross-sectional Survey and Cross-sectional Clinical Trial to Determine the Prevalence and Management of Eye Movement Disorders and Vestibular Dysfunction in Post-Stroke Patients in the Sub-Acute Phase: Protocol [O] . Andoret van Wyk, Carina A. Eksteen, Piet J. Becker, 2016

机译：一项横断面调查和横断面临床试验以确定亚急性期中风后患者的眼球运动障碍和前庭功能障碍的患病率和管理：方案
7. A cross-sectional survey and cross-sectional clinical trial to determine the prevalence and management of eye movement disorders and vestibular dysfunction in post-stroke patients in the sub-acute phase: protocol [O] . Andoret Van Wyk, Carina A Eksteen, Piet J Becker 2016

机译：一项横断面调查和横断面临床试验，以确定亚急性期卒中后患者眼球运动障碍和前庭功能障碍的患病率和管理：方案
8. Coordinating Center Models Project: A Study of Coordinating Centers in Multicenter Clinical Trials. VI. Phases of a Multicenter Clinical Trial [R] . 1979

机译：协调中心模型项目：多中心临床试验中的协调中心研究。 VI。多中心临床试验的阶段

USING VERIFIED CLINICAL TRIALS' DATABASE REGISTRY TO DETERMINE THE PREVALENCE OF AND PREVENT EXCLUSION/INCLUSION RELATED PROTOCOL VIOLATIONS IN EARLY PHASE CLINICAL TRIALS.

著录项

相似文献

相关主题

期刊订阅